Hisamitsu Pharmaceutical Co., Inc.
General ticker "HTSUF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $2.0B (TTM average)
Hisamitsu Pharmaceutical Co., Inc. follows the US Stock Market performance with the rate: 8.7%.
Estimated limits based on current volatility of 0.0%: low 29.00$, high 29.00$
Factors to consider:
- Company pays dividends (annually): last record date 2025-08-31, amount 0.41$ (Y1.41%)
Short-term HTSUF quotes
Long-term HTSUF plot
Financial data
| YTD | 2023-02-28 | 2024-02-28 | 2025-02-28 |
|---|---|---|---|
| Operating Revenue | ¥128,330.00MM | ¥141,706.00MM | ¥156,006.00MM |
| Operating Expenses | ¥116,731.00MM | ¥128,539.00MM | ¥137,111.00MM |
| Operating Income | ¥11,599.00MM | ¥13,167.00MM | ¥18,895.00MM |
| Non-Operating Income | ¥4,514.00MM | ¥6,019.00MM | ¥9,792.00MM |
| Interest Expense | ¥15.00MM | ¥18.00MM | ¥23.00MM |
| R&D Expense | ¥9,785.00MM | ¥8,614.00MM | ¥0.00MM |
| Income(Loss) | ¥16,113.00MM | ¥19,186.00MM | ¥28,687.00MM |
| Taxes | ¥3,987.00MM | ¥4,754.00MM | ¥6,385.00MM |
| Profit(Loss)* | ¥11,742.00MM | ¥13,969.00MM | ¥21,758.00MM |
| Stockholders Equity | ¥256,362.00MM | ¥264,871.00MM | ¥276,822.00MM |
| Inventory | ¥18,922.00MM | ¥21,176.00MM | ¥22,391.00MM |
| Assets | ¥313,917.00MM | ¥328,779.00MM | ¥343,068.00MM |
| Operating Cash Flow | ¥12,727.00MM | ¥18,188.00MM | ¥18,765.00MM |
| Capital expenditure | ¥7,908.00MM | ¥13,036.00MM | ¥13,774.00MM |
| Investing Cash Flow | ¥-23,868.00MM | ¥-2,512.00MM | ¥17,563.00MM |
| Financing Cash Flow | ¥-14,687.00MM | ¥-16,691.00MM | ¥-15,850.00MM |
| Earnings Per Share** | ¥148.00 | ¥181.61 | ¥295.57 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.